BLLN ▲ +0.1% - BillionToOne, Inc. $BLLN - BillionToOne Launches Northstar Origin, a New Liquid Biopsy Test to Help Identify Tissue of Origin BillionToOne shares rose 0.1% following the company's announcement of Northstar Origin, a new liquid biopsy test designed to identify the tissue of origin of cancer. The launch expands BillionToOne's portfolio of blood-based diagnostic tools, which could broaden its addressable market and revenue potential in the oncology diagnostics space. 01-SEP-2026 09:01 AM ET